| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 54.162 | 73.619 | 77.551 | 82.169 | 85.067 | 111.535 | 116.524 | 140.083 | 282.621 | 316.016 |
| Total Income - EUR | 54.162 | 73.619 | 77.551 | 82.174 | 85.293 | 111.573 | 116.563 | 140.265 | 282.630 | 316.029 |
| Total Expenses - EUR | 22.383 | 33.146 | 44.678 | 35.770 | 52.598 | 94.342 | 99.403 | 117.181 | 161.299 | 181.250 |
| Gross Profit/Loss - EUR | 31.778 | 40.473 | 32.873 | 46.404 | 32.695 | 17.231 | 17.159 | 23.085 | 121.331 | 134.779 |
| Net Profit/Loss - EUR | 30.304 | 39.737 | 32.078 | 45.582 | 31.842 | 16.170 | 16.190 | 21.710 | 118.647 | 126.436 |
| Employees | 4 | 4 | 3 | 3 | 3 | 3 | 3 | 4 | 3 | 4 |
Check the financial reports for the company - Giulia Med Inc Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 235 | 20.807 | 14.597 | 8.597 | 2.810 | 0 | 0 | 0 | 0 | 1.843 |
| Current Assets | 30.966 | 48.072 | 34.492 | 51.590 | 88.430 | 61.399 | 74.224 | 65.137 | 155.883 | 254.582 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 18 | 0 | 0 | 320 | 47.341 | -49 | 40.960 | 41.120 | 34.397 | 140.660 |
| Cash | 30.948 | 48.072 | 34.491 | 51.270 | 41.089 | 61.448 | 33.265 | 24.017 | 121.486 | 113.923 |
| Shareholders Funds | 30.349 | 39.782 | 32.130 | 59.025 | 89.724 | 16.385 | 31.605 | 14.536 | 118.889 | 244.660 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 207 | 202 | 203 | 202 | 201 |
| Debts | 924 | 29.162 | 17.168 | 1.320 | 1.643 | 45.135 | 42.669 | 50.811 | 37.479 | 12.464 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Giulia Med Inc Srl